Replies to post #157242 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Missling has previously stated the company is navigating the shortest way to market through Rett.

It makes sense if he is still pursuing a route that can secure approval out of the P2 Orphan Drug Designation trial from a clear set of endpoints being met.

It may take some time worth spending.

[plexrec]

hapit---thanks for the report---always good to hear !!!!